Company intelligence / Profile preview

HelixBind

Boxborough, Massachusetts, United Stateshelixbind.com ↗
Ownership
Private
Development stage
Preclinical
01

Overview

HelixBind has developed a proprietary molecular diagnostic platform—RaPID/BSI—that enables rapid, species-level identification of over twenty pathogens directly from whole blood within a few hours. This approach bypasses traditional blood culture methods that take days and can identify ongoing infections even in patients already receiving antimicrobials. Peer-reviewed studies have demonstrated high accuracy and low false positive rates compared to sequencing-based assays. The company’s technology aims to improve sepsis management by enabling earlier targeted antimicrobial therapy and better stewardship.

Therapeutic areas
Infectious Diseases
Modalities
DeviceMolecular diagnostic assayIn-vitro diagnostic product
Industry
Molecular Diagnostics
02

Partnerships

Academic collaboration with Tufts Medical Center for clinical evaluation/study of RaPID/BSI assay

Beyond the preview

Go deeper on HelixBind.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HelixBind.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call